dr. accordino on data from the pearl trial in hr /her2- metastatic breast cancer
Published 4 years ago • 141 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:11
dr. accordino on the utility of cdk4/6 inhibitors in hr /her2– breast cancer
-
0:36
dr. accordino on utility of liquid biopsies in breast cancer
-
10:23
sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment o...
-
4:39
asco: early studies show promise in treating metastatic breast cancer
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
8:30
progression of hr metastatic breast cancer
-
7:08
what's the best diet for hormone receptor-positive breast cancer? the ultimate guide for hr
-
16:04
living with metastatic breast cancer -erin’s story #thisismbc
-
2:31
an oncologist shares her cancer story
-
0:47
advancing precision medicine: cell-free dna fragment omics in metastatic her2-negative breast cancer
-
8:12
her2 testing in metastatic breast cancer
-
5:53
understanding metastatic breast cancer
-
1:19
asco22 metastatic breast cancer updates | sramila aithal, md | us oncology
-
1:00
dr. tolaney on remaining questions with cdk4/6 inhibitors in hr /her2- breast cancer
-
2:38
insights from the uptider program in metastatic breast cancer
-
3:27
who gets breast cancer recurrences? - with dr tasha
-
16:22
surgery for metastatic breast cancer: what are the data?
-
7:09
palbociclib endocrine therapy vs capecitabine for hr-positive her2-negative breast cancer: pearl
-
7:27
introduction and exploration of fulvestrant in metastatic breast cancer
-
50:09
ask the expert: advances in metastatic breast cancer
-
2:35
circulating tumor cells as a treatment monitoring tool in metastatic breast cancer
-
0:52
dr. graff on genomic risk prediction in hr /her2- breast cancer